首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Eurycomalongifolia: Medicinal Plant in the Prevention and Treatment of Male Osteoporosis due to Androgen Deficiency
【24h】

Eurycomalongifolia: Medicinal Plant in the Prevention and Treatment of Male Osteoporosis due to Androgen Deficiency

机译:杜仲:预防和治疗雄激素缺乏引起的男性骨质疏松症的药用植物

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoporosis in elderly men is now becoming an alarming health issue due to its relation with a higher mortality rate compared to osteoporosis in women. Androgen deficiency (hypogonadism) is one of the major factors of male osteoporosis and it can be treated with testosterone replacement therapy (TRT). However, one medicinal plant, Eurycoma longifolia Jack (EL), can be used as an alternative treatment to prevent and treat male osteoporosis without causing the side effects associated with TRT. EL exerts proandrogenic effects that enhance testosterone level, as well as stimulate osteoblast proliferation and osteoclast apoptosis. This will maintain bone remodelling activity and reduce bone loss. Phytochemical components of EL may also prevent osteoporosis via its antioxidative property. Hence, EL has the potential as a complementary treatment for male osteoporosis.
机译:由于老年女性的骨质疏松症与女性的骨质疏松症相比具有较高的死亡率,因此它已成为一个令人震惊的健康问题。雄激素缺乏症(性腺功能减退)是男性骨质疏松症的主要因素之一,可以通过睾丸激素替代疗法(TRT)进行治疗。但是,一种药用植物长叶Eurycoma Longifolia Jack(EL)可以用作预防和治疗男性骨质疏松症的替代疗法,而不会引起与TRT相关的副作用。 EL具有促雄激素作用,可增强睾丸激素水平,并刺激成骨细胞增殖和破骨细胞凋亡。这将保持骨骼重塑活动并减少骨骼损失。 EL的植物化学成分还可以通过其抗氧化特性预防骨质疏松。因此,EL有潜力作为男性骨质疏松症的补充治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号